A non-interventional, post authorisation safety study to continously monitor safety
and pregnancy outcomes in a cohort of at-risk ET subjects exposed to
Xagrid compared to other conventional cytoreductive therapies (EXELS). Status: Ongoing in most European countries. Inclusion stopped April 30 2009. Read more »
A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential
Thrombocythaemia. EudraCT # 2007-005306-49. Status: Study started in Denmark and Sweden. Norway and Finland will not participate.
Start: 2009. Read more »
Alpha-Interferon therapy of Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms. A Danish collaborative study. Status: 90 patients included in Denmark.
Start: Spring 2009. Read more »
Prospective study of Quality-of-Life in newly diagnosed MPN patients. Status: Study started in Sweden.
Start: 2009. Read more »
